US Bancorp’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-64
Closed -$99 4160
2025
Q1
$99 Sell
64
-2,038
-97% -$4.14K ﹤0.01% 4139
2024
Q4
$4.94K Buy
2,102
+1,438
+217% +$4.86K ﹤0.01% 3648
2024
Q3
$2.41K Sell
664
-718
-52% -$2.86K ﹤0.01% 3738
2024
Q2
$4.81K Sell
1,382
-2
-0.1% -$9 ﹤0.01% 3528
2024
Q1
$8.83K Hold
1,384
﹤0.01% 3368
2023
Q4
$8.91K Buy
+1,384
New +$5.28K ﹤0.01% 3339
2022
Q4
Sell
-7,652
Closed -$16K 4141
2022
Q3
$16K Buy
+7,652
New +$22.7K ﹤0.01% 3134
2022
Q2
Sell
-301
Closed -$1K 4073
2022
Q1
$1K Sell
301
-6,872
-96% -$28.9K ﹤0.01% 3910
2021
Q4
$37K Buy
7,173
+2,721
+61% +$16.3K ﹤0.01% 2802
2021
Q3
$30K Buy
4,452
+2,875
+182% +$18.2K ﹤0.01% 2905
2021
Q2
$11K Buy
1,577
+908
+136% +$5.64K ﹤0.01% 3359
2021
Q1
$4K Buy
669
+130
+24% +$962 ﹤0.01% 3534
2020
Q4
$5K Sell
539
-431
-44% -$4.59K ﹤0.01% 3385
2020
Q3
$11K Buy
970
+505
+109% +$7.32K ﹤0.01% 3038
2020
Q2
$8K Sell
465
-1,105
-70% -$12.3K ﹤0.01% 3152
2020
Q1
$10K Buy
1,570
+1,328
+549% +$12.3K ﹤0.01% 3016
2019
Q4
$3K Buy
+242
New +$3.17K ﹤0.01% 3383

Other funds holding AUTL